Hidefumi Kasai
Keio Frontier Research And Education Collaboration Square At Tonomachi
Kawasaki, 2100821, Japan
Kawasaki, 2100821, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Generating and Modeling Virtual Patient Data from Published Population Pharmacokinetic Analyses: A Vancomycin Case Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 27, 2025
Optimization of cefepime dosage regimens for Pseudomonas aeruginosa infections in Japanese patients based on a pharmacokinetic/ pharmacodynamic analysis considering efficacy and safety: Is a 6 g daily dose and continuous infusion necessary?
Journal: Global health & medicine
Published: September 11, 2025
Preclinical Study of Pharmacokinetic/Pharmacodynamic Analysis of Tebipenem Using Monte Carlo Simulation for Extended-Spectrum β-Lactamase-Producing Bacterial Urinary Tract Infections in Japanese Patients According to Renal Function.
Journal: Antibiotics (Basel, Switzerland)
Published: June 11, 2025
SCOUT: An Exploratory Approach to Scouting Dose-Relevant Covariates.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 05, 2025
Population pharmacokinetic analysis of the interaction of digoxin with N-desethylamiodarone in patients with atrial fibrillation and heart failure.
Journal: British journal of clinical pharmacology
Published: October 27, 2024
Drug-drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model.
Journal: Frontiers in microbiology
Published: August 14, 2024
Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection.
Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Published: June 22, 2023
Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis.
Journal: European journal of drug metabolism and pharmacokinetics
Published: February 12, 2023
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study.
Journal: Investigational new drugs
Published: October 31, 2022
Population Pharmacokinetic Model of Amiodarone and N-Desethylamiodarone Focusing on Glucocorticoid and Inflammation.
Journal: Biological & pharmaceutical bulletin
Published: July 05, 2022
Pharmacodynamic Model-Based Safety Management of Eribulin-Induced Myelosuppression in Patients With Breast Cancer.
Journal: Therapeutic drug monitoring
Published: May 25, 2022
Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function.
Journal: Antibiotics (Basel, Switzerland)
Published: February 22, 2022
Last Updated: 09/26/2026